More about High-Yield Cash Accounts with M1
Brokerage Accounts
Retirement Accounts
Other Accounts
Quotes are delayed by 15 minutes.
1D
1W
1M
3M
6M
YTD
1Y
2Y
5Y
ALL
Market cap
$23.44B
EPS
-0.57
P/E ratio
--
Price to sales
1.37
Dividend yield
2.347%
Beta
0.896497
Previous close
$20.74
Today's open
$20.61
Day's range
$20.41 - $20.68
52 week range
$10.15 - $21.20
show more
CEO
Scott A. Smith
Employees
30000
Headquarters
Canonsburg, PA
Exchange
Nasdaq Global Select
Shares outstanding
1.15B
Issue type
Common Stock
Healthcare
Pharmaceuticals
Viatris Inc. (VTRS) Presents at Jefferies Global Healthcare Conference 2026 Transcript
Viatris Inc. (VTRS) Presents at Jefferies Global Healthcare Conference 2026 Transcript
Seeking Alpha • 3 hours ago

Viatris Inc. (VTRS) Presents at UBS Global Biopharma Conference 2026 Transcript
Viatris Inc. (VTRS) Presents at UBS Global Biopharma Conference 2026 Transcript
Seeking Alpha • Nov 17, 2026

Are Investors Undervaluing Viatris (VTRS) Right Now?
Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.
Zacks Investment Research • a day ago

Viatris Completes Acquisition of Pacira BioSciences
PITTSBURGH, Nov. 17, 2026 /PRNewswire/ -- Viatris Inc. ("Viatris") (Nasdaq: VTRS), a global healthcare company, today announced that it has completed its acquisition of Pacira BioSciences, Inc. ("Pacira") (Nasdaq: PCRX), a leader in non-opioid pain management. The transaction was first announced on Oct. 8, 2026.
PRNewsWire • Nov 17, 2026

CADILLAC FORMULA 1® TEAM WELCOMES VIATRIS AS OFFICIAL GLOBAL PHARMACEUTICAL PARTNER
Multiyear partnership brings together a U.S.-based global healthcare company and America's new Formula 1® team INDIANAPOLIS and PITTSBURGH, Nov. 16, 2026 /PRNewswire/ -- The Cadillac Formula 1® Team and Viatris Inc. (Nasdaq: VTRS), a global healthcare company, today announced a multiyear partnership that makes Viatris the team's Official Global Pharmaceutical Partner, beginning in 2027. The partnership connects motorsport and medicine, two industries where precision, reliability and performance matter.
PRNewsWire • Nov 16, 2026

Viatris Named to Fortune's World's Best Workplaces™ List for Second Consecutive Year
PITTSBURGH, Nov. 12, 2026 /PRNewswire/ -- Viatris Inc. (Nasdaq: VTRS), a global healthcare company, today announced that it has been named to Fortune's World's Best Workplaces™ list for the second consecutive year, recognizing the Company's commitment to fostering a workplace where colleagues feel valued, supported and empowered to make an impact. The list recognizes 25 global organizations based on Great Place To Work's (GPTW) rigorous assessment process, which includes confidential employee feedback.
PRNewsWire • Nov 12, 2026

Viatris to Participate in Upcoming Investor Conferences
PITTSBURGH, Nov. 11, 2026 /PRNewswire/ -- Viatris Inc. (Nasdaq: VTRS), a global healthcare company, today announced that the Company will participate in fireside chats at three upcoming healthcare conferences. The UBS Global Biopharma Conference on November 17, 2026, at 10 a.m.
PRNewsWire • Nov 11, 2026

Viatris Inc. (VTRS) Hit a 52 Week High, Can the Run Continue?
Viatris (VTRS) is at a 52-week high, but can investors hope for more gains in the future? We take a look at the company's fundamentals for clues.
Zacks Investment Research • Nov 10, 2026

VTRS or DHR: Which Is the Better Value Stock Right Now?
Investors interested in Medical Services stocks are likely familiar with Viatris (VTRS) and Danaher (DHR). But which of these two stocks presents investors with the better value opportunity right now?
Zacks Investment Research • Nov 10, 2026

Viatris (VTRS) is a Top-Ranked Value Stock: Should You Buy?
Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.
Zacks Investment Research • Nov 6, 2026

¹ Disclosures

Open an M1 investment account to buy and sell Viatris Inc. commission-free¹. Build wealth for the long term using automated trading and transfers.